Fieldview Capital Management’s Bio-Techne TECH Stock Holding History

Fieldview Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,053	Closed	-$765K	–	514
2025 Q1	$765K	Buy	+13,053	New	+$885K	0.11%	228

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fieldview Capital Management's TECH Position: Q2 2025 in Review

Fieldview Capital Management sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 13,053 shares — an estimated $765K sold.

Fieldview Capital Management first reported a position in TECH in Q1 2025 and held it in 1 quarter. The position peaked at $765K in Q1 2025. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Fieldview Capital Management reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Fieldview Capital Management sold 13,053 Bio-Techne shares in Q2 2025, an estimated $765K.
Fieldview Capital Management first reported a position in Bio-Techne in Q1 2025 and held it in 1 quarter.
Fieldview Capital Management's Bio-Techne position peaked at $765K in Q1 2025.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Fieldview Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.